elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26822717-1D87988F-A50C-4E1E-8C6F-193859515DC7
Q26822717-1D87988F-A50C-4E1E-8C6F-193859515DC7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26822717-1D87988F-A50C-4E1E-8C6F-193859515DC7
Molecular characterizations of glioblastoma, targeted therapy, and clinical results to date
P2860
Q26822717-1D87988F-A50C-4E1E-8C6F-193859515DC7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26822717-1D87988F-A50C-4E1E-8C6F-193859515DC7
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b8e3254876df0e18b8c480319347b46dd7788a59
P2860
Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer